The Deal
Sunday, November 8, 
2:23 pm

Borrowing from Apple playbook, medical device makers focus on design, consumer appeal

  Share     E-Mail    Discussion    Print Story

The medical device sector is a curious blend of high-level science, elegant design and consumer appeal, as Thursday's $69 million funding of Pelikan Technologies Inc. demonstrates.

The deal for the integrated blood sampling and monitoring device for people with diabetes is the third-largest venture deal in the sector this year, according to the VCDeal database. Each of the most heavily funded companies in the sector have targeted areas where there is a large medical market, but where consumer choice will play a large part in the growth of the market and ultimate success of individual products.
henner.jpg
Pelikan's technology promises greater ease-of-use, less pain and greater reliability for consumers that must manage their blood glucose levels with as many as 10 blood tests a day. Backer Dennis Henner (right) of Clarus Ventures, which led the round, noted that the firm was attracted to Pelikan's combination of state-of-the-art science and innovative product design.

As the third-largest medical device deal of 2007, Pelikan's investment trails only Globus Medical Inc., which raised $110 million in August for spinal fusion products and other technology to relieve back pain, and Sientra Inc., which raised $80 million in April for breast augmentation products. Spine products are expected to be one of the fastest-growing areas in medical devices as aging baby boomers demand greater mobility and pain-free active lifestyles.

Pelikan's deal brings total venture investment in the six-year-old company to $145 million and will allow it to complete development and launch marketing of its integrated monitoring product as early as next year. - Clifford Carlsen

See Dec. 6 story from TheDeal.com
See VCDeal database
See Aug. 24 story from TheDeal.com
See April 18 story from The Deal.com

Continue reading below

Also on Dealscape





Post a comment




The Deal Pipeline

Deal Video


Inside The Deal: Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Dealing with frozen bank lending

If your bank is not willing to lend, what can you do as your company continues to seek growth?


Judgment Call

The coming age of the renminbi

The Chinese currency will play an increasingly important role in international commerce and finance.


Industry Insight

Banking on PE investments

Howls of protest greeted the FDIC policy statement, but the financial services industry should get over it.



©Copyright 2008, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.